Another group reported that ZFX could bind to a certain sequence on human c‐Myc promoter to upregulate its expression, thus maintaining the stem‐like phenotypes and tumorigenic potential of glioma stem cells (Fang et al., 2014). The gene discussed is MYC; the disease is central nervous system cancer.